iSpecimen Inc. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
iSpecimen Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • iSpecimen Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.71M, a 22.3% increase year-over-year.
  • iSpecimen Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$9.76M, a 6.53% increase year-over-year.
  • iSpecimen Inc. annual Operating Income (Loss) for 2023 was -$11.2M, a 9.65% decline from 2022.
  • iSpecimen Inc. annual Operating Income (Loss) for 2022 was -$10.2M, a 71.9% decline from 2021.
  • iSpecimen Inc. annual Operating Income (Loss) for 2021 was -$5.93M, a 146% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$11.2M -$983K -9.65% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 -$10.2M -$4.26M -71.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$5.93M -$3.52M -146% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-03-30
2020 -$2.41M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.